Henry Schein, Inc. Plans to Reduce Board Members by Approximately 33%

DentalGoodNews | April 8, 2026 – Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced plans to reduce the size of its Board of Directors from 15 to 10 members following its Annual Meeting of Stockholders on May 21, 2026, representing a reduction of approximately 33%.

According to previous reports by DGN, Stanley M. Bergman, Chairman and Chief Executive Officer who has served Henry Schein for over 40 years, plans to retire by the end of 2025. This announcement clarifies that Bergman will formally step down from the Board after the May meeting and will be granted the title of "Chairman Emeritus" in recognition of his long-term contributions to the company. Following his departure, he will continue to support the Board and management team in this new capacity.

Regarding the Board restructuring, four current directors – Joseph L. Herring, Robert J. Hombach, Scott Serota, and Bradley T. Sheares – will not stand for re-election. As previously reported by DGN, Henry Schein has announced that Fred Lowery will succeed as Chief Executive Officer. The slate of director nominees for re-election includes Mohamad Ali, William K. "Dan" Daniel, Deborah Derby, Carole T. Faig, Kurt P. Kuehn, Philip A. Laskawy, Max Lin, Frederick M. Lowery, Anne H. Margulies, and Reed V. Tuckson.

Headquartered in Melville, New York, Henry Schein is one of the world's largest providers of healthcare solutions to office-based dental and medical practitioners. As of 2025, the company reported annual sales of $13.2 billion, employs approximately 25,000 people globally, and operates in 34 countries and territories. The Board believes the streamlined structure will maintain a balance of experience and skills while enhancing the efficiency of decision-making and communication.